The Flowr Corporation
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- The Flowr Corporation engages in the production and sale of premium cannabis products, operating primarily through its Flowr Canada and Holigen segments. Its core offerings include high-quality dried cannabis flower, pre-rolls, cannabis oils, and emerging product formats such as vape cartridges, edibles, beverages, and topical applications. The company emphasizes non-irradiated cannabis cultivated using advanced indoor growing techniques in its Okanagan Valley facility in British Columbia, designed to optimize yield, quality, and product consistency. It supplies both the medicinal and adult-use cannabis markets across Canada, with a commercial presence also established in Portugal through its Holigen segment. The Flowr Corporation maintains a dual-brand strategy, marketing FlowrRx for the medical market and Flowr for premium adult-use consumers. Founded in 2016 and headquartered in Toronto, Canada, the company partners with Hawthorne Gardening, a subsidiary of Scotts Miracle-Gro, through an exclusive R&D alliance to advance cannabis cultivation and product development. Recent strategic developments include the completion of the acquisition of Terrace Global, enhancing Flowr's production capacity and international footprint. The company undertook a significant restructuring program to rightsize its workforce and reduce operating expenses, aligning operations with evolving market demands. Flowr has also divested non-core assets, including the sale of its Kelowna facility and Okanagan operations to focus on core competencies. Product innovation continues with the launch of new cannabis strains such as Strawnana, Sour Sis, and BC Dog Walkers to meet growing consumer demand. These moves reflect Flowr's shift towards optimizing profitability and reinforcing its position in premium cannabis segments in Canada and internationally, with ongoing efforts to expand and supply regulated adult-use and medical cannabis markets.
Akanda buys Portugal unit of Canada's Flowr
Flowr Corp Sells Kelowna Research Facility To Hawthorne For $16M, Launches Four New Cannabis Strains
Flowr Corp sells R&D station to Hawthorne Canada
Flowr Corp Reports Slight YoY Rise In Q3 Revenue, Continues Development Of New Genetics
The Flowr Corporation - ATM Program Quarterly Update
The Flowr Corporation Awarded Gold Effie for Marketing Effectiveness
The Flowr Corporation Announces Resignation of Director
The Flowr Corporation Announces Second Quarter and First Half 2021 Results
The Flowr Corporation Announces Second Quarter 2021 Earnings Date
The Flowr Corporation Provides Operational Update
Berner's Cookies Teams Up With The Flowr Corp. To Bring Its Products To EU Via Portugal
The Flowr Corporation Announces Appointment to the Board of Directors
Urban-gro, The Flowr, Hexo & KushCo Among Top Cannabis Movers For August 4, 2021
Flowr Corp Confirms Its First Sale Of Medical Cannabis In Portugal, Largest To Date In European Union
The Flowr Corporation Announces First Sale of Medical Cannabis in Portugal
The Flowr Corporation Secures Over Half A Million Via Offering Of Units To Partially Repay Its Debt
The Flowr Corporation Announces Closing of Non-Brokered Offering of Securities
The Flowr Corporation Announces Closing of Offering of Securities
Flowr Cannabis Co Announces $7.01M Offering Of Units And $1M In Direct Placement, Aims To Partly Repay Its Debt
The Flowr Corporation Announces Offering of Securities